Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Duodenal Fluid Microbiome Diversity and Pancreatic Cyst Status Among Patients Undergoing Pancreatic Surveillance.

Gastro hep advances·2026
Same author

Short-Term Outcomes of Laparoscopic Hiatal Hernia Repair with Consecutive Transoral Incisionless Fundoplication: A Prospective Multicenter Cohort Study.

Journal of the American College of Surgeons·2026
Same author

Factors affecting compliance with pancreas surveillance in patients with familial/genetic risk.

Familial cancer·2026
Same author

Reply.

Gastro hep advances·2026
Same author

Targeted KEAP1 disruption enhances antioxidant defense and mesenchymal stromal cell therapy for chronic limb-threatening ischemia.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Antireflux Surgery for Barrett's Esophagus: Where Do We Stand in Preventing Esophageal Adenocarcinoma?

Annals of the New York Academy of Sciences·2026

Related Experiment Video

Updated: May 24, 2026

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models
09:18

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models

Published on: February 3, 2026

Pancreatic cancer screening.

Eun Ji Shin1, Marcia Irene Canto

  • 1Department of Internal Medicine, Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

Gastroenterology Clinics of North America
|February 21, 2012
PubMed
Summary
This summary is machine-generated.

Abdominal imaging can detect early pancreatic neoplasms in high-risk individuals. Early detection of these precursor pancreatic cancers (FPCs) improves resectability, but selecting patients for preventive treatment remains challenging.

More Related Videos

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

Related Experiment Videos

Last Updated: May 24, 2026

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models
09:18

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models

Published on: February 3, 2026

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

Area of Science:

  • Gastroenterology
  • Oncology
  • Radiology

Background:

  • Inherited predispositions increase risk for pancreatic neoplasms.
  • Early detection of precursor pancreatic neoplasms (FPCs) is crucial for improving outcomes.
  • Clinically available imaging like EUS and MRI/MRCP can detect asymptomatic FPCs.

Purpose of the Study:

  • To review the role of abdominal imaging in detecting asymptomatic pancreatic neoplasms in high-risk individuals.
  • To highlight the challenges in selecting high-grade precursor lesions for preventive treatment.
  • To suggest future research directions for risk modeling and cost-effectiveness analysis.

Main Methods:

  • Review of current data on abdominal imaging (EUS, MRI/MRCP) for pancreatic neoplasm detection.
  • Analysis of the resectability of asymptomatic versus symptomatic FPCs.
  • Discussion of challenges in risk stratification and selection for preventive therapy.

Main Results:

  • EUS and MRI/MRCP can detect asymptomatic benign and malignant pancreatic neoplasms in high-risk individuals.
  • Asymptomatic FPCs are more likely to be resectable than symptomatic tumors.
  • Selection of individuals with high-grade precursor neoplasms for preventive treatment is a significant challenge.

Conclusions:

  • Abdominal imaging plays a vital role in detecting early pancreatic neoplasms in at-risk populations.
  • Further research is needed to develop validated models for FPC risk and progression.
  • Screening should currently be conducted within research protocols at specialized academic centers.